v3.26.1
Segment Reporting - Schedule of Information by Segments (Details) - CODM [Member] - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Information by Segments [Line Items]    
Cost of revenue $ 2,333,460 $ 240,966
Gross profit 2,774,927 474,396
Selling expense 1,804,797  
General and administrative expense 3,883,166 1,803,479
Depreciation & amortization 102,031 37,208
Income tax expense 110,632 18,594
Capital expenditure   155,991
Long-lived assets 734,989 841,336
Segment assets 17,780,651 3,315,823
Segment profit (loss) (3,452,877) (1,529,602)
External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue from external customers 5,108,387 715,362
Pharmaceutical distribution (China) [Member]    
Schedule of Information by Segments [Line Items]    
Cost of revenue 2,333,460 240,966
Gross profit 2,774,927 474,396
Selling expense 1,785,669  
General and administrative expense 481,389 246,685
Depreciation & amortization 36,556 4,262
Income tax expense 126,661 26,608
Capital expenditure   155,991
Long-lived assets 400,377 348,179
Segment assets 3,774,605 1,090,942
Segment profit (loss) 246,745 70,616
Pharmaceutical distribution (China) [Member] | External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue from external customers 5,108,387 715,362
Holding [Member]    
Schedule of Information by Segments [Line Items]    
Cost of revenue
Gross profit
Selling expense 19,128  
General and administrative expense 3,401,777 1,556,794
Depreciation & amortization 65,475 32,946
Income tax expense (16,029) (8,014)
Capital expenditure  
Long-lived assets 334,612 493,157
Segment assets 14,006,046 2,224,881
Segment profit (loss) (3,699,622) (1,600,218)
Holding [Member] | External Customers [Member]    
Schedule of Information by Segments [Line Items]    
Revenue from external customers